Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir.
about
The alliance of mesenchymal stem cells, bone, and diabetesWnt5a/Ror2 mediates temporomandibular joint subchondral bone remodelingA fully human inhibitory monoclonal antibody to the Wnt receptor RYKAryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass.Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fracturesWnt5a regulates dental follicle stem/progenitor cells of the periodontium.Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.Efavirenz is associated with higher bone mass in South African children with HIV.Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA PathwaysThe protease inhibitors and HIV-associated bone loss.Establishing estrogen-responsive mouse mammary organoids from single Lgr5+ cells.HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.WNT receptors profile expression in mature blood cells and immature leukemic cells: RYK emerges as a hallmark receptor of acute leukemia.Bone Loss in HIV Infection.Bone mineral density in people living with HIV: a narrative review of the literature.Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.A targeted approach to genome-wide studies reveals new genetic associations with central corneal thickness.WNT5A and Its Receptors in the Bone-Cancer Dialogue.Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.
P2860
Q27012497-E4FE9915-4471-45DC-916F-17F7EFE63DDAQ28574949-43C353B8-CE05-40D9-93A4-C98BA225ACE8Q34995094-B2744254-2227-4CED-8DA3-619FED480EF3Q35007314-FA08219B-839F-4335-A37F-2F19BF466BABQ35360217-8B8A68B2-6047-4EC9-92C6-8375553D3A72Q35655305-4D110B51-D65B-41F5-BB5E-CA8D347C2F55Q35861519-178F9593-F7D4-44BB-9717-4D2F221D1F60Q36079798-8BA6CB06-D3C1-4945-8C84-46D0F0E0AD2FQ36535535-01099875-C262-4A9B-8A1F-AA2962E4FF1EQ36593417-B2149FC2-F0F3-4837-9547-FF2F4628F2A2Q36818259-79612F50-E454-4AEA-B5F8-1F2BBA70F235Q37474790-40DEFFD4-8EEC-4ECE-A1E1-0CE93F9C9031Q38055705-F8508E10-7546-4121-8E89-098EFC5A9C38Q38820001-7551B3BE-196D-4E21-90CD-424F93778ABCQ38835028-8F32F904-B900-484F-AD7B-6DD7A758ED02Q40107245-E49F5D04-D4EB-4D9B-AAEA-8FC8E88F6531Q40401577-60E58C59-580E-4737-A16A-B5117E0C0D91Q47110127-D13E604A-8F39-47A1-9916-E6A7157CF38CQ51674853-0FED0B57-6EDE-441A-A4D7-B272DA38A2B5Q54956715-F4A47D77-B41B-45FC-8B65-080DFCAC43F6
P2860
Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@ast
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@en
type
label
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@ast
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@en
prefLabel
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@ast
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@en
P2093
P2860
P1476
Noncanonical Wnt signaling pro ...... protease inhibitor ritonavir.
@en
P2093
Anthony M C Brown
Francisco Santiago
Jeffrey Laurence
Junya Oguma
P2860
P304
P356
10.1016/J.BBRC.2011.11.089
P407
P577
2011-11-28T00:00:00Z